Literature DB >> 15499115

Individual response to treatment: is it a valid assumption?

Stephen Senn1.   

Abstract

Mesh：

Year:  2004        PMID： 15499115      PMCID： PMC524113          DOI： 10.1136/bmj.329.7472.966

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  On subgroups and groping for significance.

Authors:  S Senn; F E Harrell
Journal:  J Clin Epidemiol       Date:  1998-12       Impact factor: 6.437

Review 2.  Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research.

Authors:  W Kalow; B K Tang; L Endrenyi
Journal:  Pharmacogenetics       Date:  1998-08

3.  Applying results of randomised trials to patients. N of 1 trials are needed.

Authors:  S Senn
Journal:  BMJ       Date:  1998-08-22

Review 4.  Interpreting treatment effects in randomised trials.

Authors:  G H Guyatt; E F Juniper; S D Walter; L E Griffith; R S Goldstein
Journal:  BMJ       Date:  1998-02-28

5.  On wisdom after the event.

Authors:  S Senn; F Harrell
Journal:  J Clin Epidemiol       Date:  1997-07       Impact factor: 6.437

6.  Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation.

Authors:  R I Horwitz; B H Singer; R W Makuch; C M Viscoli
Journal:  J Clin Epidemiol       Date:  1996-04       Impact factor: 6.437
  6 in total
  37 in total

1.  Every prescription is a clinical trial.

Authors:  Alfred P J Lake
Journal:  BMJ       Date:  2004-12-04

Review 2.  Why is the grass greener?

Authors:  Barbara Starfield
Journal:  BMJ       Date:  2005-03-26

3.  Clinical trial results applied to management of the individual cancer patient.

Authors:  Ismail Jatoi; Michael A Proschan
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

Review 4.  Biomarkers in oncology drug development.

Authors:  Darren R Hodgson; Robin D Whittaker; Athula Herath; Dereck Amakye; Glen Clack
Journal:  Mol Oncol       Date:  2008-12-11       Impact factor: 6.603

5.  Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages.

Authors:  Richard L Kravitz; Naihua Duan; Joel Braslow
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

6.  Group analysis versus individual response: the inferential limits of randomized controlled trials.

Authors:  John M Kelley; Ted J Kaptchuk
Journal:  Contemp Clin Trials       Date:  2010-07-16       Impact factor: 2.226

7.  Transcriptional markers in response to hydrocortisone in sepsis in ADRENAL: a step toward precision medicine.

Authors:  Timothy E Sweeney; Hector R Wong
Journal:  Intensive Care Med       Date:  2021-08-10       Impact factor: 17.440

8.  Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT).

Authors:  Hillary R Bogner; Knashawn H Morales; Edward P Post; Martha L Bruce
Journal:  Diabetes Care       Date:  2007-08-23       Impact factor: 19.112

9.  Adverse Cardiovascular Response to Aerobic Exercise Training: Is This a Concern?

Authors:  Eric S Leifer; Catherine R Mikus; Laura Karavirta; Benjamin D Resnick; William E Kraus; Keijo Häkkinen; Conrad P Earnest; Jerome L Fleg
Journal:  Med Sci Sports Exerc       Date:  2016-01       Impact factor: 5.411

10.  Dealing with heterogeneity of treatment effects: is the literature up to the challenge?

Authors:  Nicole B Gabler; Naihua Duan; Diana Liao; Joann G Elmore; Theodore G Ganiats; Richard L Kravitz
Journal:  Trials       Date:  2009-06-19       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.